Most people with SCD seem to meet or exceed current level of physical activity recommendations for the general population, a ...

Columnist Oluwatosin Adesoye shares her thoughts about the role of World Sickle Cell Day in promoting sickle cell awareness.

BEAM-101, a treatment for sickle cell disease, showed sustained efficacy and safety over one year in the BEACON Phase 1/2 ...

Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela ...

The treatment’s developer, Beam Therapeutics, shared data from the first 17 patients dosed in the trial in a presentation, “Base editing for sickle cell disease: ongoing results from the BEACON study ...